Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 USD | +11.59% | +20.78% | +254.02% |
05-10 | Kiromic BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-01 | Kiromic BioPharma, Inc. announced that it has received $2 million in funding | CI |
Business Summary
Number of employees: 35
Managers
Managers | Title | Age | Since |
---|---|---|---|
Scott Dahlbeck
FOU | Founder | 62 | 05/08/06 |
Pietro Bersani
CEO | Chief Executive Officer | 56 | 31/05/20 |
Brian Hungerford
DFI | Director of Finance/CFO | 49 | 11/06/23 |
Chief Operating Officer | 43 | 29/02/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Nagel
CHM | Chairman | 62 | 31/05/20 |
Pamela Misajon
BRD | Director/Board Member | 65 | 19/07/23 |
Pietro Bersani
CEO | Chief Executive Officer | 56 | 31/05/20 |
Scott Dahlbeck
FOU | Founder | 62 | 05/08/06 |
Michael Catlin
BRD | Director/Board Member | - | 19/07/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,288,235 | 1,044,738 ( 81.10 %) | 0 | 81.10 % |
Stock B | 0 | 14,000 | 0 | 0 |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+254.02% | 3.56M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- KRBP Stock
- Company Kiromic BioPharma, Inc.